• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

CADx gets approvable letter

Article

Another developer of computer-assisted detection systems may be close to entering the market. CADx Medical Systems of Quebec has received an FDA approvable letter for its CAD mammography system. Final approval would clear the way for the company to sell

Another developer of computer-assisted detection systems may be close to entering the market. CADx Medical Systems of Quebec has received an FDA approvable letter for its CAD mammography system. Final approval would clear the way for the company to sell its film-based Second Look product in the U.S. Only the company's combination film digitizer and image report generator would be allowed to enter the U.S. market. Software packages that the company is developing for integration with digital mammography systems from Fischer Imaging and Hologic would not be affected. CADx has been selling Second Look overseas for close to a year. About 25 systems have been installed in more than a dozen countries. List price outside the U.S. is $169,000.

Related Videos
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Assessing the Impact of Radiology Workforce Shortages in Rural Communities
Emerging MRI and PET Research Reveals Link Between Visceral Abdominal Fat and Early Signs of Alzheimer’s Disease
Reimbursement Challenges in Radiology: An Interview with Richard Heller, MD
Related Content
© 2024 MJH Life Sciences

All rights reserved.